<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01546636</url>
  </required_header>
  <id_info>
    <org_study_id>EH10-184</org_study_id>
    <nct_id>NCT01546636</nct_id>
  </id_info>
  <brief_title>The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position</brief_title>
  <official_title>The Effect of Ventilation on Cerebral Oxygenation in the Sitting Position</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NorthShore University HealthSystem Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this clinical investigation is to determine the effect of intraoperative
      ventilation on cerebral oxygen saturation in patients undergoing arthroscopic shoulder
      surgery in the beach chair position (BCP)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent developments in near-infrared spectroscopy technology now permit rapid assessment of
      cerebral oxygenation (SctO2) using non-invasive probes. A high incidence cerebral
      desaturation events (CDE-defined as a decrease in SctO2 values below 20% of baseline measures
      or absolute SctO2 values ≤ 55 for ≥ 15 seconds) have been observed in previous investigation
      of patients undergoing shoulder surgery in BCP with hyperventilation. The investigators
      hypothesize that the incidence of CDE will be reduced in patients ventilated at normocapnic
      levels (end-tidal carbon dioxide values (ETCO2) of 40-42 mm Hg) when compared to subjects
      hyperventilated (ETCO2 of 30-32 mm Hg) in the operating room. Patients undergoing shoulder
      surgery in the BCP will be randomized to a hypocapnic group (ETCO2 of 30-32 mm Hg) or a
      normocapnic group (ETCO2 of 40-42 mm Hg). Cerebral oxygenation will be measured continuously
      throughout the procedure to assess perioperative SctO2 values and the incidence of CDE. The
      investigators previously observed an association between CDE in the operating room and
      postoperative nausea and vomiting. Therefore, the effect of ventilatory pattern and
      intraoperative SctO2 on clinical recovery will also be determined.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Cerebral Desaturation Events</measure>
    <time_frame>Intraoperative-first 2 hours</time_frame>
    <description>Cerebral desaturation events were measured with near-infrared spectroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Patients Experiencing Nausea and Vomiting</measure>
    <time_frame>Postanesthesia care unit-first 2 hours</time_frame>
    <description>Assessed by recovery nurses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postanesthesia Care Unit Length of Stay (Total Time)</measure>
    <time_frame>Approximately 5 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Cerebral Ischemia</condition>
  <arm_group>
    <arm_group_label>Hypocapnic group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normocapnic group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypocapnic group</intervention_name>
    <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
    <arm_group_label>Hypocapnic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normocapnic group</intervention_name>
    <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
    <arm_group_label>Normocapnic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for elective shoulder arthroscopy under general anesthesia in the
             BCP.

        Exclusion Criteria:

          -  Exclusion criteria include 1) history of pre-existing cerebrovascular disease or
             orthostatic hypotension 2) age &lt; 18 years 3) American Society of Anesthesiologists
             Physical Status IV or V.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn S. Murphy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2012</study_first_submitted>
  <study_first_submitted_qc>March 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <results_first_submitted>July 16, 2013</results_first_submitted>
  <results_first_submitted_qc>November 22, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 17, 2013</results_first_posted>
  <last_update_submitted>March 11, 2015</last_update_submitted>
  <last_update_submitted_qc>March 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem Research Institute</investigator_affiliation>
    <investigator_full_name>Glenn S. Murphy, MD</investigator_full_name>
    <investigator_title>Director, Cardiac Anesthesia and Clinical Research</investigator_title>
  </responsible_party>
  <keyword>Cerebral desaturation events</keyword>
  <keyword>Cerebral oximetry</keyword>
  <keyword>Beach chair position</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 70 patients presenting for elective shoulder surgery at NorthShore University HealthSystem were enrolled in the clinical trial.</recruitment_details>
      <pre_assignment_details>All enrolled participants completed the study, and complete data was collected on all subjects.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Hypocapnic Group</title>
          <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
        </group>
        <group group_id="P2">
          <title>Normocapnic Group</title>
          <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The number of participants was determined by performing a sample size calculation.</population>
      <group_list>
        <group group_id="B1">
          <title>Hypocapnic Group</title>
          <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
        </group>
        <group group_id="B2">
          <title>Normocapnic Group</title>
          <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.3" spread="13.8"/>
                    <measurement group_id="B2" value="54.7" spread="12.4"/>
                    <measurement group_id="B3" value="53.3" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Cerebral Desaturation Events</title>
        <description>Cerebral desaturation events were measured with near-infrared spectroscopy</description>
        <time_frame>Intraoperative-first 2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnic Group</title>
            <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
          </group>
          <group group_id="O2">
            <title>Normocapnic Group</title>
            <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Cerebral Desaturation Events</title>
          <description>Cerebral desaturation events were measured with near-infrared spectroscopy</description>
          <units>number of events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients Experiencing Nausea and Vomiting</title>
        <description>Assessed by recovery nurses</description>
        <time_frame>Postanesthesia care unit-first 2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnic Group</title>
            <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
          </group>
          <group group_id="O2">
            <title>Normocapnic Group</title>
            <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients Experiencing Nausea and Vomiting</title>
          <description>Assessed by recovery nurses</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postanesthesia Care Unit Length of Stay (Total Time)</title>
        <time_frame>Approximately 5 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Hypocapnic Group</title>
            <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
          </group>
          <group group_id="O2">
            <title>Normocapnic Group</title>
            <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
          </group>
        </group_list>
        <measure>
          <title>Postanesthesia Care Unit Length of Stay (Total Time)</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.5" lower_limit="23" upper_limit="267"/>
                    <measurement group_id="O2" value="69" lower_limit="19" upper_limit="133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Until the time of hospital discharge</time_frame>
      <desc>Patients were followed until hospital discharge</desc>
      <group_list>
        <group group_id="E1">
          <title>Hypocapnic Group</title>
          <description>Patients will be ventilated to an ETCO2 of 30-32 mm Hg.</description>
        </group>
        <group group_id="E2">
          <title>Normocapnic Group</title>
          <description>Patients will be ventilated to an ETCO2 of 40-42 mm Hg</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There were no technical limitations to the trial</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Glenn Murphy, MD, Director of Clinical Research</name_or_title>
      <organization>NorthShore University HealthSystem</organization>
      <phone>847-570-2760</phone>
      <email>gmurphy@northshore.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

